Jim Simons Tg Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$13.32 - $19.19 $7.08 Million - $10.2 Million	-531,229 Reduced 63.2%	309,371 $5.5 Million
Q1 2024 May 13, 2024	BUY	$13.02 - $21.3 $18,228 - $29,820	1,400 Added 0.17%	840,600 $12.8 Million
Q4 2023 Feb 13, 2024	SELL	$6.68 - $18.81 $3.59 Million - $10.1 Million	-537,262 Reduced 39.03%	839,200 $14.3 Million
Q3 2023 Nov 14, 2023	BUY	$8.36 - $26.5 $7.02 Million - $22.3 Million	840,262 Added 156.71%	1,376,462 $11.5 Million
Q2 2023 Aug 11, 2023	BUY	$15.48 - $35.0 $8.3 Million - $18.8 Million	536,200 New	536,200 $13.3 Million
Q4 2022 Feb 13, 2023	SELL	$5.01 - $11.83 $401,301 - $947,583	-80,100 Reduced 44.7%	99,100 $1.17 Million
Q3 2022 Nov 14, 2022	SELL	$4.57 - $8.4 $4.58 Million - $8.42 Million	-1,001,900 Reduced 84.83%	179,200 $1.06 Million
Q2 2022 Aug 12, 2022	BUY	$3.74 - $10.66 $3.68 Million - $10.5 Million	983,500 Added 497.72%	1,181,100 $5.02 Million
Q1 2022 May 13, 2022	SELL	$7.81 - $20.45 $402,996 - $1.06 Million	-51,600 Reduced 20.71%	197,600 $1.88 Million
Q4 2021 Feb 11, 2022	BUY	$15.2 - $35.51 $3.79 Million - $8.85 Million	249,200 New	249,200 $4.74 Million
Q3 2021 Nov 12, 2021	SELL	$21.78 - $40.45 $3.18 Million - $5.9 Million	-145,800 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$32.5 - $48.96 $383,500 - $577,728	11,800 Added 8.81%	145,800 $5.66 Million
Q1 2021 May 13, 2021	SELL	$41.61 - $54.3 $9.74 Million - $12.7 Million	-234,000 Reduced 63.59%	134,000 $6.46 Million
Q4 2020 Feb 10, 2021	BUY	$25.27 - $54.9 $6.81 Million - $14.8 Million	269,400 Added 273.23%	368,000 $19.1 Million
Q3 2020 Nov 13, 2020	SELL	$18.49 - $27.24 $19.5 Million - $28.8 Million	-1,056,800 Reduced 91.47%	98,600 $2.64 Million
Q2 2020 Aug 13, 2020	BUY	$8.9 - $21.84 $5.73 Million - $14.1 Million	643,600 Added 125.75%	1,155,400 $22.5 Million
Q1 2020 May 14, 2020	SELL	$7.14 - $15.99 $4.77 Million - $10.7 Million	-667,700 Reduced 56.61%	511,800 $5.04 Million
Q4 2019 Feb 13, 2020	BUY	$5.1 - $11.2 $5.46 Million - $12 Million	1,070,706 Added 984.16%	1,179,500 $13.1 Million
Q3 2019 Nov 13, 2019	SELL	$5.38 - $8.99 $278,178 - $464,836	-51,706 Reduced 32.22%	108,794 $611,000
Q2 2019 Aug 12, 2019	BUY	$6.27 - $8.65 $717,288 - $989,560	114,400 Added 248.16%	160,500 $1.39 Million
Q1 2019 May 14, 2019	SELL	$4.02 - $8.04 $3.34 Million - $6.67 Million	-829,800 Reduced 94.74%	46,100 $371,000
Q4 2018 Feb 13, 2019	BUY	$3.44 - $5.76 $3.01 Million - $5.05 Million	875,900 New	875,900 $3.59 Million

Others Institutions Holding TGTX

# of Institutions

338

Shares Held

88.3M

Call Options Held

2.35M

Put Options Held

1.7M

Vanguard Group Inc Valley Forge, PA

15.4M
Shares

$455 Million
0.01% of portfolio
Black Rock Inc. New York, NY

11.4M
Shares

$336 Million
0.0% of portfolio
State Street Corp Boston, MA

9.09M
Shares

$269 Million
0.01% of portfolio
Pictet Asset Management Holding Sa Carouge, V8

3.58M
Shares

$106 Million
0.1% of portfolio
Geode Capital Management, LLC Boston, MA

3.21M
Shares

$94.7 Million
0.01% of portfolio

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account